Stay updated on Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study data, eligibility criteria, or locations observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section added with California sites; California locations list updated under v3.3.3.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page, with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange Detected- Revision history updated: added v3.3.1 and removed v3.2.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a general notice about government funding and NIH operating status that previously appeared on the page. The study details and links remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedNo significant additions or deletions were detected between the two screenshots; the page content and layout appear unchanged.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Enobosarm in AR+ Metastatic TNBC Clinical Trial page.